Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective estrogen-receptor modulators for primary prevention of breast cancer.

× No keyword cloud information.

27 in total

1. Quantitative proteomic analysis revealed lovastatin-induced perturbation of cellular pathways in HL-60 cells.

Authors: Xiaoli Dong; Yongsheng Xiao; Xinning Jiang; Yinsheng Wang
Journal: J Proteome Res Date: 2011-10-21 Impact factor: 4.466

Review 2. Molecular targets for cancer chemoprevention.

Authors: William N William; John V Heymach; Edward S Kim; Scott M Lippman
Journal: Nat Rev Drug Discov Date: 2009-03 Impact factor: 84.694

3. A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.

Authors: Nicole M Kretzer; Milu T Cherian; Chengjian Mao; Irene O Aninye; Philip D Reynolds; Rachel Schiff; Paul J Hergenrother; Steven K Nordeen; Elizabeth M Wilson; David J Shapiro
Journal: J Biol Chem Date: 2010-11-01 Impact factor: 5.157

4. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.

Authors: Florence Gizard; Romain Robillard; Barbara Gross; Olivier Barbier; Françoise Révillion; Jean-Philippe Peyrat; Gérard Torpier; Dean W Hum; Bart Staels
Journal: Mol Cell Biol Date: 2006-10 Impact factor: 4.272

Review 5. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors: Balazs I Bodai; Phillip Tuso
Journal: Perm J Date: 2015

6. Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Authors: Carol J Fabian; Bruce F Kimler; Carola M Zalles; Teresa A Phillips; Trina Metheny; Brian K Petroff; Thomas C Havighurst; KyungMann Kim; Howard H Bailey; Brandy M Heckman-Stoddard
Journal: Cancer Prev Res (Phila) Date: 2015-09-21

7. Raloxifene induces autophagy-dependent cell death in breast cancer cells via the activation of AMP-activated protein kinase.

Authors: Dong Eun Kim; Yunha Kim; Dong-Hyung Cho; Seong-Yun Jeong; Sung-Bae Kim; Nayoung Suh; Jung Shin Lee; Eun Kyung Choi; Jae-Young Koh; Jung Jin Hwang; Choung-Soo Kim
Journal: Mol Cells Date: 2014-12-24 Impact factor: 5.034

Selective estrogen-receptor modulators for primary prevention of breast cancer.